GlassScriptPhysician profile
Lisa L Wilson
NPI 1245666452
$1,171.82
in general payments reported to CMS, 2019-2025
23 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $185 · 2023: $314 · 2024: $400 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $265.02 | 2021-2024 | |
| Pfizer INC. | $140.53 | 2022-2024 | |
| Medtronic, INC. | $80.98 | 2022-2023 | Linq II |
| Amgen INC. | $75.77 | 2023-2025 | Repatha, Repatha |
| Inspire Medical Systems, INC. | $72.10 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $59.23 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $57.16 | 2021-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.57 | 2021-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $43.08 | 2024-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $42.54 | 2022-2024 | Verquvo |
| Abbott Laboratories | $39.08 | 2021-2023 | Cardiomems |
| Cvrx, INC. | $38.60 | 2022 | |
| Ethicon US, LLC | $29.41 | 2025 | Stratafix, Vistaseal |
| Novo Nordisk INC | $22.99 | 2024 | Wegovy |
| Alnylam Pharmaceuticals INC. | $21.94 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $20.50 | 2025 | Attruby |
| Abiomed | $18.94 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.67 | 2025 | Lifevest |
| Amarin Pharma, INC. | $16.16 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.49 | 2021 | |
| Astellas Pharma US INC | $15.19 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $13.73 | 2024 | |
| Boston Scientific Corporation | $13.14 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.